$LOAN
MANHATTAN BRIDGE CAPITAL, INC Stock $loan

$loan Overview Financials Valuation SEC Filings Company Website

2013 Form 10-K Financial Statement

#000114420414017236 Filed on March 24, 2014

Income Statement

Concept	2013	2012 Q4	2012
Revenue	$2.260M	$520.0K	$1.816M
YoY Change	24.45%	40.54%	29.68%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$840.0K	$320.0K	$860.0K
YoY Change	-2.33%	6.67%	-1.15%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$840.0K	$320.0K	$870.0K
YoY Change	-3.45%	6.67%	0.0%
Operating Profit	$977.4K		$664.4K
YoY Change	47.12%
Interest Expense	-$440.0K	-$90.00K	-$280.0K
YoY Change	57.14%	80.0%	75.0%
% of Operating Profit	-45.02%		-42.14%
Other Income/Expense, Net	-$7.452K	$10.00K	$27.55K
YoY Change	-127.05%	0.0%	-65.57%
Pretax Income	$970.0K	$110.0K	$691.9K
YoY Change	40.18%	266.67%	53.76%
Income Tax	$387.0K	$80.00K	$303.3K
% Of Pretax Income	39.9%	72.73%	43.84%
Net Earnings	$583.0K	$30.00K	$388.6K
YoY Change	50.01%	-400.0%	49.47%
Net Earnings / Revenue	25.8%	5.77%	21.4%
Basic Earnings Per Share	$0.14		$0.09
Diluted Earnings Per Share	$0.14	$6.711K	$0.09
COMMON SHARES
Basic Shares Outstanding	4.269M shares		4.320M shares
Diluted Shares Outstanding	4.290M shares		4.326M shares

Balance Sheet

Concept	2013	2012 Q4	2012
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.020M	$240.0K	$240.0K
YoY Change	325.0%	9.09%	9.09%
Cash & Equivalents	$1.020M	$240.7K	$240.0K
Short-Term Investments
Other Short-Term Assets	$20.00K	$18.90K	$20.00K
YoY Change	0.0%	-5.49%	0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$11.91M	$11.44M	$11.44M
YoY Change	4.11%	57.61%	57.58%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00	$0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$210.0K	$250.0K	$250.0K
YoY Change	-16.0%	0.0%	0.0%
Other Assets	$10.00K	$50.00K	$50.00K
YoY Change	-80.0%	-37.5%	-37.5%
Total Long-Term Assets	$4.210M	$2.897M	$2.900M
YoY Change	45.17%	2.35%	2.47%
TOTAL ASSETS
Total Short-Term Assets	$11.91M	$11.44M	$11.44M
Total Long-Term Assets	$4.210M	$2.897M	$2.900M
Total Assets	$16.12M	$14.34M	$14.34M
YoY Change	12.41%	42.11%	42.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$60.00K	$70.00K	$70.00K
YoY Change	-14.29%	16.67%	16.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.320M	$1.399M	$1.900M
YoY Change	-30.53%	20.64%	63.79%
Long-Term Debt Due	$5.350M	$4.000M	$3.500M
YoY Change	52.86%
Total Short-Term Liabilities	$7.230M	$5.860M	$5.860M
YoY Change	23.38%	290.69%	290.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.230M	$5.860M	$5.860M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$7.230M	$5.860M	$5.860M
YoY Change	23.38%	193.0%	193.0%
SHAREHOLDERS EQUITY
Retained Earnings		-$942.6K
YoY Change
Common Stock		$9.692M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)		$270.0K
YoY Change
Treasury Stock Shares		107.1K shares
Shareholders Equity	$8.890M	$8.479M	$8.480M
YoY Change
Total Liabilities & Shareholders Equity	$16.12M	$14.34M	$14.34M
YoY Change	12.41%	42.11%	42.12%

Cashflow Statement

Concept	2013	2012 Q4	2012
OPERATING ACTIVITIES
Net Income	$583.0K	$30.00K	$388.6K
YoY Change	50.01%	-400.0%	49.47%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change
Cash From Operating Activities	$790.0K	$220.0K	$530.0K
YoY Change	49.06%	175.0%	39.47%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.070M	-$940.0K	-$4.210M
YoY Change	-74.58%	16.05%	200.71%
Cash From Investing Activities	-$1.070M	-$940.0K	-$4.210M
YoY Change	-74.58%	16.05%	200.71%
FINANCING ACTIVITIES
Cash Dividend Paid	$128.0K		$0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.070M	750.0K	3.700M
YoY Change	-71.08%	-350.0%	330.23%
NET CHANGE
Cash From Operating Activities	790.0K	220.0K	530.0K
Cash From Investing Activities	-1.070M	-940.0K	-4.210M
Cash From Financing Activities	1.070M	750.0K	3.700M
Net Change In Cash	790.0K	30.00K	20.00K
YoY Change	3850.0%	-102.91%	-112.5%
FREE CASH FLOW
Cash From Operating Activities	$790.0K	$220.0K	$530.0K
Capital Expenditures	$0.00
Free Cash Flow	$790.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240693	USD
CY2012Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1399465	USD
CY2012Q4	loan	Short Term Loans Receivable ShortTermLoansReceivable	11022866	USD
CY2013Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	171483	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	18903	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	18540	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	11442804	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	11908996	USD
CY2012Q4	us-gaap	Security Deposit SecurityDeposit	6491	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1021023	USD
CY2013Q4	loan	Short Term Loans Receivable ShortTermLoansReceivable	10697950	USD
CY2012Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	160342	USD
CY2012Q4	us-gaap	Cost Method Investments CostMethodInvestments	100000	USD
CY2013Q4	us-gaap	Cost Method Investments CostMethodInvestments	65000	USD
CY2012Q4	us-gaap	Assets Assets	14339351	USD
CY2013Q4	us-gaap	Assets Assets	16124454	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	4405	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9687159	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	269972	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-942607	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14339351	USD
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	20649	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	4433	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9745249	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	369335	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-487660	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	8892687	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16124454	USD
CY2012Q4	loan	Investment In Real Estate InvestmentInRealEstate	146821	USD
CY2013Q4	loan	Investment In Real Estate InvestmentInRealEstate	146821	USD
CY2012Q4	loan	Long Term Loans Receivable LongTermLoansReceivable	2601500	USD
CY2013Q4	loan	Long Term Loans Receivable LongTermLoansReceivable	3997000	USD
CY2013Q4	us-gaap	Security Deposit SecurityDeposit	6637	USD
CY2012Q4	loan	Deferred Finance Costs DeferredFinanceCosts	41735	USD
CY2013Q4	loan	Deferred Finance Costs DeferredFinanceCosts	0	USD
CY2012Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	3500000	USD
CY2013Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5350000	USD
CY2012Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	500000	USD
CY2013Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	0	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	70403	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	57066	USD
CY2012Q4	loan	Deferred Origination Fees DeferredOriginationFees	122242	USD
CY2013Q4	loan	Deferred Origination Fees DeferredOriginationFees	132017	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	268256	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	373219	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5860366	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7231767	USD
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1319465	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	8478985	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4405190	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4433190	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4298059	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4256190	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	107131	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	177000	shares
CY2012	loan	Interest Income From Loans InterestIncomeFromLoans	1475800	USD
CY2013	loan	Interest Income From Loans InterestIncomeFromLoans	1858033	USD
CY2012	loan	Origination Fees OriginationFees	339767	USD
CY2013	loan	Origination Fees OriginationFees	401514	USD
CY2012	us-gaap	Revenues Revenues	1815567	USD
CY2013	us-gaap	Revenues Revenues	2259547	USD
CY2012	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	280654	USD
CY2013	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	442661	USD
CY2012	loan	Referral Fees ReferralFees	6133	USD
CY2013	loan	Referral Fees ReferralFees	1679	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	864398	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	837788	USD
CY2012	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1151185	USD
CY2013	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1282128	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	664382	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	977419	USD
CY2012	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	27548	USD
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4320050	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4326329	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4289818	shares
CY2013	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	27548	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	691930	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	969967	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	303320	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	387000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	388610	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-217	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10331	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13337	USD
CY2012	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	-9462	USD
CY2013	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	-9775	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	582967	USD
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4269169	shares
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	8088068	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30879	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35578	USD
CY2012	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	28572	USD
CY2013	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	99363	USD
CY2012	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	47078	USD
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	41735	USD
CY2012	us-gaap	Depreciation Nonproduction DepreciationNonproduction	588	USD
CY2013	us-gaap	Depreciation Nonproduction DepreciationNonproduction	0	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	30879	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	35578	USD
CY2012	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	50437	USD
CY2013	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	11141	USD
CY2012	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2582	USD
CY2012	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	99470	USD
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	104963	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	533399	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	785757	USD
CY2012	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	15173500	USD
CY2013	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	15159450	USD
CY2012	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	10963486	USD
CY2013	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	14088866	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4210014	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1070584	USD
CY2012	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	3740000	USD
CY2013	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	1770000	USD
CY2012	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	28572	USD
CY2013	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	99363	USD
CY2012	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	16025	USD
CY2013	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3695403	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1065157	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	18788	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	780330	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	221905	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	203850	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	283084	USD
CY2012	us-gaap	Interest Paid InterestPaid	234835	USD
CY2013	us-gaap	Interest Paid InterestPaid	400925	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"><i>Use of Estimates</i></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management will base the use of estimates on (a) a preset number of assumptions that consider past experience, (b) future projections, and (c) general financial market condition. Actual amounts could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"><i>Concentrations of Credit Risk</i></font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"><i>  </i></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash and cash equivalents with one major financial institution. Accounts at the financial institution are insured by the Federal Deposit Insurance Corporation up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black">Credit risks associated with short term commercial loans the Company makes to small businesses and related interest receivable are described in Note 4 entitled Commercial Loans.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6279	shares
CY2013Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	345721	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	262351	shares
CY2013	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P15Y
CY2012Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount Commercial LoansAndLeasesReceivableGrossCarryingAmountCommercial	13624366	USD
CY2013Q4	loan	Additional Construction Loan For Borrowers Subject To Conditions AdditionalConstructionLoanForBorrowersSubjectToConditions	1017500	USD
CY2013Q4	loan	Commercial Loans Issued To Borrowers CommercialLoansIssuedToBorrowers	3750950	USD
CY2012Q4	loan	Jointly Funded Loans Total JointlyFundedLoansTotal	510000	USD
CY2013Q4	loan	Jointly Funded Loans Total JointlyFundedLoansTotal	2400000	USD
CY2012Q4	loan	Jointly Funded Loans JointlyFundedLoans	255000	USD
CY2013Q4	loan	Jointly Funded Loans JointlyFundedLoans	1650000	USD
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.96
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.02
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.53
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.65
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.97
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.92
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.97
CY2011Q4	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term Outstanding Option ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermOutstandingOption	P2Y3M4D
CY2012Q4	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term Outstanding Option ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermOutstandingOption	P1Y7M13D
CY2011Q1	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	675000	USD
CY2011Q1	loan	Option Sold OptionSold	3900	USD
CY2011Q1	loan	Option Monthly Fee OptionMonthlyFee	10530	USD
CY2011Q4	loan	Exercise Price Of Remaining Property ExercisePriceOfRemainingProperty	146821	USD
CY2011Q4	loan	Monthly Option Fee For Property After Partial Exercise Of Option MonthlyOptionFeeForPropertyAfterPartialExerciseOfOption	2296	USD
CY2013	loan	Fees Generated From Seller Buy Back Options FeesGeneratedFromSellerBuyBackOptions	27548	USD
CY2013	us-gaap	Finite Lived Intangible Assets Amortization Method FiniteLivedIntangibleAssetsAmortizationMethod	straight-line method
CY2010Q4	loan	Senior Long Term Notes Under Private Placement SeniorLongTermNotesUnderPrivatePlacement	500000	USD
CY2010	loan	Senior Notes Maturity Date SeniorNotesMaturityDate	December 2013
CY2010Q4	us-gaap	Loans Pledged As Collateral LoansPledgedAsCollateral	750000	USD
CY2010	loan	Common Stock Issued To Underwriter Value CommonStockIssuedToUnderwriterValue	11683	USD
CY2010	loan	Number Of Warrants Issued To Underwriter NumberOfWarrantsIssuedToUnderwriter	20000	shares
CY2010Q4	loan	Exercise Price Of Warrants Issued To Underwriter ExercisePriceOfWarrantsIssuedToUnderwriter	2.50
CY2008	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	36395	USD
CY2010	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	36395	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	241995	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	306900	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	61325	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	80100	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	303320	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	387000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	7838	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	8766	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	86226	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	78388	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	94064	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	192354	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94064	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	192354	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.06	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2012	loan	Effective Income Tax Rate Reconciliation State And Local Franchise Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalFranchiseTaxes	0	pure
CY2013	loan	Effective Income Tax Rate Reconciliation State And Local Franchise Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalFranchiseTaxes	0	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.44	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.4	pure
CY2012	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	7400	USD
CY2013	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	3800	USD
CY2013	us-gaap	Defined Contribution Plan Number Of Employees Covered DefinedContributionPlanNumberOfEmployeesCovered	100	pure
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	348000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	28000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	28000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.01
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.92
CY2013	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodGross	28000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	21000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	70000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	355000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	285000	shares
CY2012Q4	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableNumber	352000	shares
CY2013Q4	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableNumber	283000	shares
CY2012	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodGross	0	shares
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	29000	shares
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	3000	shares
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2000	shares
CY2011Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.01
CY2013Q4	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term Outstanding Option ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermOutstandingOption	P1Y5M5D
CY2012Q4	loan	Share Based Compensation Arrangement By Share Based Payment Award Option Weighted Average Remaining Contractual Term For Vested And Exercisable Options ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionWeightedAverageRemainingContractualTermForVestedAndExercisableOptions	P1Y7M6D
CY2013Q4	loan	Share Based Compensation Arrangement By Share Based Payment Award Option Weighted Average Remaining Contractual Term For Vested And Exercisable Options ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionWeightedAverageRemainingContractualTermForVestedAndExercisableOptions	P1Y5M1D
CY2011Q4	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Vested And Non Vested Options Outstanding Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardVestedAndNonVestedOptionsOutstandingIntrinsicValue	177253	USD
CY2012Q4	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Vested And Non Vested Options Outstanding Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardVestedAndNonVestedOptionsOutstandingIntrinsicValue	173006	USD
CY2013Q4	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Vested And Non Vested Options Outstanding Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardVestedAndNonVestedOptionsOutstandingIntrinsicValue	147656	USD
CY2012Q4	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Vested And Exercisable Aggregate Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardVestedAndExercisableAggregateIntrinsicValue	171208	USD
CY2013Q4	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Vested And Exercisable Aggregate Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardVestedAndExercisableAggregateIntrinsicValue	146458	USD
CY2011Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4000	shares
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	29000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.02
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.53
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.02
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.51
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.01
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.01
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	285000	shares
CY2013Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.97
CY2013	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P1Y5M5D
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	283000	shares
CY2013Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.97
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	Under our stock option plan, every non-employee director of the Company is granted 7,000 options upon first taking office, and then 7,000 upon each additional year in office. Generally, options outstanding vest over periods not exceeding four years and are exercisable for up to five years from the grant date.
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30879	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35578	USD
CY2013	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	13065	USD
CY2011	loan	Fair Value Of Restricted Shares Granted FairValueOfRestrictedSharesGranted	195968	USD
CY2013	loan	Fair Value Of Restricted Shares Amortization Period FairValueOfRestrictedSharesAmortizationPeriod	P15Y
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.746	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.746	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.75	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.75	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0073	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0073	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0107	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0107	pure
CY2011Q3	loan	Market Price Per Share On Date Of Restricted Shares Grant MarketPricePerShareOnDateOfRestrictedSharesGrant	1.21
CY2011Q3	loan	Restriction On Exercise Of Additional Options Held By Ceo Below Prescribed Exercise Price Limit RestrictionOnExerciseOfAdditionalOptionsHeldByCeoBelowPrescribedExercisePriceLimit	210000	shares
CY2011Q3	loan	Description Of Terms Of Restricted Shares Agreement DescriptionOfTermsOfRestrictedSharesAgreement	Until their expiration, Mr. Ran will be required to forfeit approximately 4.76 Restricted Shares for each share of Common Stock issued upon any exercise of the Remaining Options.
CY2012Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	100000	shares
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	40300	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	41400	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	28100	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	109800	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	38000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	39000	USD
CY2011	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	80000	USD
CY2011Q4	loan	Amount Of Personal Guarantee Commitment Provided By Defendant AmountOfPersonalGuaranteeCommitmentProvidedByDefendant	5000000	USD
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Trading Symbol TradingSymbol	LOAN
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4256190	shares
CY2013	dei	Entity Registrant Name EntityRegistrantName	MANHATTAN BRIDGE CAPITAL, INC
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001080340
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	dei	Entity Public Float EntityPublicFloat	2665132	USD
CY2013	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	80000	USD
CY2012	loan	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMinimum	0	pure
CY2013	loan	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMinimum	0	pure
CY2012	loan	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMaximum	0.0261	pure
CY2013	loan	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMaximum	0.0261	pure
CY2012	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	0	USD
CY2013	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	35000	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	27548	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7452	USD
CY2013	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
CY2012	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	500000	USD
CY2012	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	22540	USD
CY2012	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2013	us-gaap	Payments Of Dividends PaymentsOfDividends	128020	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	22540	USD
CY2013	us-gaap	Dividends Dividends	128020	USD
CY2012Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	147000	USD
CY2013Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	147000	USD
CY2013Q4	loan	Aggregate Percentage Of Commercial Loans Issued AggregatePercentageOfCommercialLoansIssued	0.255	pure
CY2011	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvestedoutstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedoutstandingWeightedAverageRemainingContractualTerm	P4Y10M17D
CY2012	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvestedoutstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedoutstandingWeightedAverageRemainingContractualTerm	P3Y10M17D
CY2013	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvestedoutstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedoutstandingWeightedAverageRemainingContractualTerm	P2Y10M17D
CY2012	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Grants In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantsInPeriodWeightedAverageRemainingContractualTerm	P4Y6M
CY2013	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Grants In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantsInPeriodWeightedAverageRemainingContractualTerm	P4Y6M
CY2012	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Vested In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedVestedInPeriodWeightedAverageRemainingContractualTerm	P4Y5M23D
CY2013	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Vested In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedVestedInPeriodWeightedAverageRemainingContractualTerm	P4Y5M8D
CY2012Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	105200	USD

Files In Submission

Name	View Source	Status
0001144204-14-017236-index-headers.html	Edgar Link	pending
0001144204-14-017236-index.html	Edgar Link	pending
0001144204-14-017236.txt	Edgar Link	pending
0001144204-14-017236-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
loan-20131231.xml	Edgar Link	completed
loan-20131231.xsd	Edgar Link	pending
loan-20131231_cal.xml	Edgar Link	unprocessable
loan-20131231_def.xml	Edgar Link	unprocessable
loan-20131231_lab.xml	Edgar Link	unprocessable
loan-20131231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tsig.jpg	Edgar Link	pending
v371655_10k.htm	Edgar Link	pending
v371655_ex23-1.htm	Edgar Link	pending
v371655_ex31-1.htm	Edgar Link	pending
v371655_ex31-2.htm	Edgar Link	pending
v371655_ex32-1.htm	Edgar Link	pending
v371655_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LOAN
MANHATTAN BRIDGE CAPITAL, INC Stock $loan

2013 Form 10-K Financial Statement

#000114420414017236 Filed on March 24, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN MANHATTAN BRIDGE CAPITAL, INC Stock $loan

2013 Form 10-K Financial Statement

#000114420414017236 Filed on March 24, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN
MANHATTAN BRIDGE CAPITAL, INC Stock $loan